The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients. (SORT)

AstraZeneca

Status: Completed

Conditions: Essential Hypertension

Study type: Observational

Funder types: Industry

Identifiers

NCT01295021

NIS-CIN-DUM-2010/2

Details and patient eligibility

About

The purpose of this NIS is to assess the prevalence of sympathetic overactivity in patients with newly diagnosed essential hypertension.

Full description

MC MD

Enrollment: 1,514 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Newly diagnosed essential hypertension patients will be eligible for the study.
• Average of two or more systolic BP readings ≥ 140mmHg or diastolic BP readings ≥ 90mmHg

Exclusion criteria

• History of coronary artery disease
• History of diabetes